T1	ANAT 10 20	intestinal
#1	AnnotatorNotes T1	C0021853; Intestines; Body Part, Organ, or Organ Component | C1318303; Entire intestine; Body Part, Organ, or Organ Component
T2	PROC 26 38	colonoscopia
#2	AnnotatorNotes T2	C0009378; colonoscopy; Diagnostic Procedure
T3	DISO 75 91	efectos adversos
#3	AnnotatorNotes T3	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T4	PROC 154 173	limpieza intestinal
#4	AnnotatorNotes T4	C0455052; Bowel preparation; Therapeutic or Preventive Procedure
T5	ANAT 163 173	intestinal
#5	AnnotatorNotes T5	C0021853; Intestines; Body Part, Organ, or Organ Component | C1318303; Entire intestine; Body Part, Organ, or Organ Component
T6	PROC 976 1003	efectividad fue determinada
#6	AnnotatorNotes T6	C1707887; Efficacy Study; Research Activity
T7	PROC 228 239	diagnóstico
#7	AnnotatorNotes T7	C0011900; Diagnosis; Diagnostic Procedure
T8	PROC 252 264	colonoscopia
#8	AnnotatorNotes T8	C0009378; colonoscopy; Diagnostic Procedure
T9	PROC 507 519	colonoscopia
#9	AnnotatorNotes T9	C0009378; colonoscopy; Diagnostic Procedure
T10	PROC 542 561	Estudio descriptivo
T11	PROC 606 618	colonoscopia
#10	AnnotatorNotes T11	C0009378; colonoscopy; Diagnostic Procedure
T12	CHEM 698 707	glicerina
#11	AnnotatorNotes T12	C0017861; glycerin; Organic Chemical · Biologically Active Substance · Pharmacologic Substance
T13	CHEM 736 752	polietilenglicol
#12	AnnotatorNotes T13	C0032483; polyethylene glycols; Organic Chemical · Pharmacologic Substance
T14	CHEM 754 757	PEG
#13	AnnotatorNotes T14	C0032483; polyethylene glycols; Organic Chemical · Pharmacologic Substance
T15	CHEM 769 781	electrolitos
#14	AnnotatorNotes T15	C0013832; Electrolytes; Pharmacologic Substance · Inorganic Chemical
T16	CHEM 809 812	PEG
#15	AnnotatorNotes T16	C0032483; polyethylene glycols; Organic Chemical · Pharmacologic Substance
T17	CHEM 823 835	electrolitos
#16	AnnotatorNotes T17	C0013832; Electrolytes; Pharmacologic Substance · Inorganic Chemical
T18	CHEM 838 848	bisacodilo
#17	AnnotatorNotes T18	C0005632; bisacodyl; Organic Chemical · Pharmacologic Substance
T19	CHEM 868 871	PEG
#18	AnnotatorNotes T19	C0032483; polyethylene glycols; Organic Chemical · Pharmacologic Substance
T20	CHEM 882 894	electrolitos
#19	AnnotatorNotes T20	C0013832; Electrolytes; Pharmacologic Substance · Inorganic Chemical
T21	DISO 955 971	efectos adversos
#20	AnnotatorNotes T21	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T22	PROC 1012 1024	colonoscopia
#21	AnnotatorNotes T22	C0009378; colonoscopy; Diagnostic Procedure
T23	DISO 1442 1455	estreñimiento
#22	AnnotatorNotes T23	C0009806; Constipation; Sign or Symptom | C0221152; Obstipation; Disease or Syndrome
T24	DISO 1539 1555	efectos adversos
#23	AnnotatorNotes T24	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T25	PROC 1664 1690	suspensión del medicamento
#24	AnnotatorNotes T25	C0850893; stop medication; Therapeutic or Preventive Procedure
T26	PROC 1727 1738	preparación
#25	AnnotatorNotes T26	C0455052; Bowel preparation; Therapeutic or Preventive Procedure
T27	PROC 1922 1931	protocolo
#26	AnnotatorNotes T27	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T28	PROC 430 440	protocolos
#27	AnnotatorNotes T28	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T29	DISO 410 426	efectos adversos
#28	AnnotatorNotes T29	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T30	ANAT 1954 1964	intestinal
#29	AnnotatorNotes T30	C0021853; Intestines; Body Part, Organ, or Organ Component | C1318303; Entire intestine; Body Part, Organ, or Organ Component
T31	PROC 1 20	Limpieza intestinal
#30	AnnotatorNotes T31	C0455052; Bowel preparation; Therapeutic or Preventive Procedure
T32	LIVB 42 47	niños
#31	AnnotatorNotes T32	C0008059; Child; Age Group
T36	LIVB 473 494	pacientes pediátricos
#32	AnnotatorNotes T36	C0030705; Patients; Patient or Disabled Group + C0008059; Child; Age Group
T37	LIVB 522 531	Pacientes
#33	AnnotatorNotes T37	C0030705; Patients; Patient or Disabled Group
T38	LIVB 574 583	pacientes
#34	AnnotatorNotes T38	C0030705; Patients; Patient or Disabled Group
T39	Age 584 593	< 18 años
T41	Age 672 681	< 6 meses
T42	Form 683 694	supositorio
#35	AnnotatorNotes T42	C0038854; Suppository; Biomedical or Dental Material
T45	Neg_cue 765 768	sin
T46	Age 784 807	4 años-9 años, 11 meses
T48	Neg_cue 819 822	sin
T49	Age 851 866	10 años-18 años
T50	LIVB 1123 1132	pacientes
#36	AnnotatorNotes T50	C0030705; Patients; Patient or Disabled Group
T51	Age 1192 1198	4 años
T52	Age 1206 1220	un mes-17 años
T53	LIVB 1260 1269	pacientes
#37	AnnotatorNotes T53	C0030705; Patients; Patient or Disabled Group
T54	Age 1306 1315	< 6 meses
T55	Age 1324 1334	10-18 años
T56	Age 1354 1377	4 años-9 años, 11 meses
T58	LIVB 1514 1523	pacientes
#38	AnnotatorNotes T58	C0030705; Patients; Patient or Disabled Group
T59	LIVB 1576 1585	pacientes
#39	AnnotatorNotes T59	C0030705; Patients; Patient or Disabled Group
T60	Age 1613 1623	10-18 años
T61	Neg_cue 1645 1647	no
T63	LIVB 1826 1835	pacientes
#40	AnnotatorNotes T63	C0030705; Patients; Patient or Disabled Group
T64	PHYS 1947 1964	hábito intestinal
#41	AnnotatorNotes T64	C0011135; Defecation; Organism Function
T33	Age 710 734	6 meses-3 años, 11 meses
T34	LIVB 1158 1165	varones
#42	AnnotatorNotes T34	C0025266; Male population group; Population Group
A1	Population_data T32 Age
A2	Population_data T36 Age
A3	Assertion T15 Negated
A4	Assertion T17 Negated
A5	Assertion T25 Negated
T35	Neg_cue 318 320	no
T40	CONC 325 333	consenso
A6	Assertion T40 Negated
R1	Negation Arg1:T35 Arg2:T40	
R2	Negation Arg1:T61 Arg2:T25	
R3	Negation Arg1:T48 Arg2:T17	
R4	Negation Arg1:T45 Arg2:T15	
T43	Spec_cue 1884 1890	podría
T44	CONC 1891 1898	deberse
A7	Assertion T44 Speculated
#43	AnnotatorNotes T44	C0015127; Etiology aspects; Functional Concept (?) | C1314792; Etiology; Functional Concept (?)
R5	Location_of Arg1:T1 Arg2:T31	
R6	Before Arg1:T31 Arg2:T2	
R7	Experiences Arg1:T32 Arg2:T2	
R8	Experiences Arg1:T32 Arg2:T31	
T47	Observation 62 72	adherencia
#44	AnnotatorNotes T47	C2364172; Adherence To Medication Regime; Finding
R9	Experiences Arg1:T32 Arg2:T47	
R10	Experiences Arg1:T32 Arg2:T3	
R11	Before Arg1:T2 Arg2:T3	
R12	Location_of Arg1:T5 Arg2:T4	
R13	Before Arg1:T4 Arg2:T8	
R14	Before Arg1:T8 Arg2:T7	
T57	Observation 397 407	adherencia
#45	AnnotatorNotes T57	C2364172; Adherence To Medication Regime; Finding
R15	Experiences Arg1:T36 Arg2:T29	
R16	Experiences Arg1:T36 Arg2:T57	
R17	Experiences Arg1:T36 Arg2:T9	
R18	Before Arg1:T9 Arg2:T29	
R19	Has_Age Arg1:T38 Arg2:T39	
R20	Experiences Arg1:T38 Arg2:T11	
R21	Has_Age Arg1:T37 Arg2:T39	
R22	Experiences Arg1:T37 Arg2:T11	
R23	Has_Drug_Form Arg1:T12 Arg2:T42	
R24	Overlap Arg1:T12 Arg2:T41	
R25	Overlap Arg1:T14 Arg2:T33	
R26	Overlap Arg1:T13 Arg2:T33	
R27	Overlap Arg1:T15 Arg2:T33	
R28	Overlap Arg1:T15 Arg2:T33	
R29	Overlap Arg1:T16 Arg2:T46	
R30	Overlap Arg1:T17 Arg2:T46	
R31	Overlap Arg1:T18 Arg2:T46	
R32	Combined_with Arg1:T16 Arg2:T18	
R33	Combined_with Arg1:T19 Arg2:T20	
R34	Overlap Arg1:T19 Arg2:T49	
R35	Overlap Arg1:T20 Arg2:T49	
T62	CONC 912 930	datos demográficos
#46	AnnotatorNotes T62	C4684639; Demographic Data; Intellectual Product
T65	CONC 912 917;932 940	datos clínicos
#47	AnnotatorNotes T65	C1516606; Clinical Data; Intellectual Product
T66	Observation 942 952	adherencia
#48	AnnotatorNotes T66	C2364172; Adherence To Medication Regime; Finding
T67	CONC 1072 1078	Boston
#49	AnnotatorNotes T67	C4302285; BBPS - Boston bowel preparation scale; Intellectual Product
T68	Quantifier_or_Qualifier 1079 1089	modificada
R36	Has_Quantifier_or_Qualifier Arg1:T67 Arg2:T68	
R37	Used_for Arg1:T67 Arg2:T6	
R38	Has_Age Arg1:T34 Arg2:T51	
R39	Has_Age Arg1:T34 Arg2:T52	
R40	Has_Age Arg1:T50 Arg2:T51	
R41	Has_Age Arg1:T50 Arg2:T52	
R42	Overlap Arg1:T23 Arg2:T56	
T69	Observation 1480 1496	buena adherencia
R43	Experiences Arg1:T58 Arg2:T69	
R44	Experiences Arg1:T59 Arg2:T24	
R45	Has_Age Arg1:T59 Arg2:T60	
T70	Quantifier_or_Qualifier 1637 1642	leves
#50	AnnotatorNotes T70	C2945599; Mild (qualifier value); Qualitative Concept
R46	Has_Quantifier_or_Qualifier Arg1:T24 Arg2:T70	
R47	Experiences Arg1:T59 Arg2:T25	
R49	Experiences Arg1:T63 Arg2:T26	
R50	Speculation Arg1:T43 Arg2:T44	
R51	Location_of Arg1:T30 Arg2:T64	
#51	AnnotatorNotes T69	C4700175; Good = 95% adherence; Finding (?)
A8	Experiencer T59 Patient
A9	Experiencer T58 Patient
A10	Experiencer T63 Patient
A11	Experiencer T32 Patient
A12	Experiencer T36 Patient
A13	Experiencer T37 Patient
A14	Experiencer T38 Patient
A15	Experiencer T50 Patient
A16	Experiencer T34 Patient
A17	Experiencer T53 Patient
